Short-term effect of combined drug therapy and cognitive stimulation therapy on the cognitive function of Alzheimer's disease

Psychogeriatrics

Volumn 10, Issue 4, 2010, Pages 167-172

  Matsuda, Osamu ^a   Shido, Emi ^b   Hashikai, Ayako ^c   Shibuya, Haruka ^d   Kouno, Mitsue ^e   Hara, Chizuko ^f   Saito, Masahiko ^b  

^a TOKYO GAKUGEI UNIVERSITY   (Japan)

^b Wako Hospital   (Japan)

^c Midorigaoka Hospital   (Japan)

^d Tokyo Metropolitan Foundation for Social Welfare and Public Health   (Japan)

^e Apricot Medical Clinic   (Japan)

^f Anryuen Nursing Home   (Japan)

Author keywords

Alzheimer's disease; Cognitive rehabilitation; Cognitive stimulation therapy; Non pharmacological treatment

Indexed keywords

DONEPEZIL;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; OUTPATIENT; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; PSYCHOPHARMACOTHERAPY; THERAPY EFFECT; TREATMENT DURATION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CHOLINESTERASE INHIBITORS; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INDANS; MALE; MATHEMATICS; NEUROPSYCHOLOGICAL TESTS; PIPERIDINES; PROBLEM SOLVING; READING; VERBAL LEARNING;

EID: 78650132438     PISSN: 13463500     EISSN: 14798301     Source Type: Journal    
DOI: 10.1111/j.1479-8301.2010.00335.x     Document Type: Article

References (21)

1. United Nations. World Population Prospects: The 2006 Revision: Sex and Age Distribution of the World Population (Department of Economic and Social Affairs-Population Studies). New York: United Nations Publications, 2007.
2. Matsuda O, Saito M. Functional competency and cognitive ability in mild Alzheimer's disease: relationship between ADL assessed by a relative/ carer-rated scale and neuropsychological performance. Int Psychogeriatr 2005; 17: 275-288.
3. Matsuda O, Saito M. Multiple cognitive deficits in patients during the mild cognitive impairment stage of Alzheimer's disease: how are cognitive domains other than episodic memory impaired? Int Psychogeriatr 2009; 21: 970-976.
4. Chapman SB, Weiner MF, Rackley A, Hynan LS, Zientz J. Effects of cognitive-communication stimulation for Alzheimer's disease patients treated with donepezil. J Speech Lang Hear Res 2004; 47: 1149-1163.
5. Bottino CMC, Carvalho IAM, Alvarez AMMA etal. Cognitive rehabilitation combined with drug treatment in Alzheimer's disease patients: a pilot study. Clin Rehabil 2005; 19: 861-869.
6. Kawashima R, Okita K, Yamazaki R etal. Reading aloud and arithmetic calculation improve frontal function of people with dementia. J Gerontol A Biol Sci Med Sci 2005; 60: 380-384.
7. Matsuda O. Cognitive stimulation therapy for Alzheimer's disease: the effect of cognitive stimulation therapy on the progression of mild Alzheimer's disease in patients treated with donepezil. Int Psychogeriatr 2007; 19: 241-252.
8. Orrell M, Spector A, Thorgrimsen L, Woods B. A pilot study examining the effectiveness of maintenance Cognitive Stimulation Therapy (MCST) for people with dementia. Int J Geriatr Psychiatry 2005; 20: 446-451.
9. Requena C, Lopez Ibor MI, Maestu F, Campo P, Lopez Ibor JJ, Ortiz T. Effects of cholinergic drugs and cognitive training on dementia. Dement Geriatr Cogn Disord 2004; 18: 50-54.
10. Yoshida H, Kawashima R, Sugimoto K etal. Effect of performance in learning tasks on cognitive functions in the aged with dementia. Jpn J Geriatr Psychiatry 2004; 15: 319-325 (in Japanese).
11. Elfgren CI, Risberg J. Lateralized frontal blood flow increases during fluency tasks: influence of cognitive strategy. Neuropsychologia 1998; 36: 505-512.
12. Clare L, Woods RT, Moniz Cook ED, Orrell M, Spector A. Cognitive rehabilitation and cognitive training for early-stage Alzheimer's disease and vascular dementia. Cochrane Database Syst Rev 2003; 1-46. Hoboken, NJ: John Wiley & Sons, 2004.
13. American Psychiatric Association. Diagnostic and Statstical Manual of Mental Disorders, 4th edn. Washington: American Psychiatric Association, 1994.
14. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944.
15. Clare L, Wilson BA, Carter G, Breen K, Gosses A, Hodges JR. Intervening with everyday memory problems in dementia of Alzheimer type: an errorless learning approach. J Clin Exp Neuropsychol 2000; 22: 132-146.
16. Kato S, Shimogaki H, Onodera A etal. Development of the revised version of Hasegawa's Dementia Scale (HDS-R). Jap J Geriatr Psychiatry 1991; 2: 1339-1347 (in Japanese).
17. Haebara T. Quasi-experimentation and single case experimentation. In: Haebara T, Ichikawa S, Shimoyama H, eds. Introduction to Research Methods in Psychology Surveys, Experiments and Practices. Tokyo: University of Tokyo Press, 2001; 123-152 (in Japanese).
18. Rockwood K, Joyce B, Stolee P. Use of goal attainment scaling in measuring clinically important change in cognitive rehabilitation patients. J Clin Epidemiol 1997; 50: 581-588.
19. Kesslak JP, Nalcioglu O, Cotman CW. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease. Neurology 1991; 41: 51-54.
20. Lantons PL, Cairns NJ. The neuropsychology of Alzheimer's disease. In: Burns A, Levy R, eds. Dementia. London: Chapman & Hall Medical, 1994; 185-207.
21. Imran MB, Kawashima R, Awata S etal. Parametric mapping of cerebral blood flow deficits in Alzheimer's disease: a SPECT study using HMPAO and image standarization techniqu. J Nucl Med 1999; 40: 244-249.